Skip to main content

Table 6 Changes in Model for End-Stage Liver Disease score in the studied groups before infusion, after 2 weeks and 1, 2, 3, 6, 9 and 12 months

From: The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency

Study group

Pre-treatment

1 month

2 months

3 months

6 months

9 months

12 months

Control group

17.20 ± 1.32

16.13 ± 1.54

16.47 ± 1.43

17.00 ± 1.68

17.24 ± 1.90

17.15 ± 1.95

16.32 ± 3.70

Single infusion

17.60 ± 1.90

15.73 ± 2.89

14.90 ± 3.24*

14.48 ± 3.11*

14.64 ± 2.92*

14.86 ± 2.57*

14.96 ± 2.39*

Double infusion

17.23 ± 1.33

15.53 ± 1.99

15.03 ± 1.81*

14.57 ± 1.56*

14.07 ± 1.72*

13.97 ± 1.74*#

13.96 ± 1.59*#

  1. Data presented as mean ± standard deviation
  2. * P <0.05 between single infusion or repeated infusion and control groups
  3. # P <0.05 between single-infusion and repeated-infusion groups